Biorasis, Inc. is a privately held company committed to developing a wireless, needle-implantable (0.5 x 0.5 x 5 mm) biosensor platform for real time, continuous metabolite monitoring.

Some of our strengths include:

• Significant R&D experience of our team in various fields including (1) electrochemical sensors; (2) drug-delivery coatings; (3) analog/mixed signal circuits; (4) semiconductor packaging; (5) quality control.
• Solid IP portfolio with a holistic approach to developing a continuous metabolic monitoring system.
• Well cited publications to support the technology.
• Numerous peer-reviewed state and federal grants that attests to the confidence in our approach.